Manulife (Manufacturers Life Insurance)’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,391
| Closed | -$54.2K | – | 3012 |
|
|
2024
Q1 | $54.2K | Buy |
+2,391
| New | +$54.2K | ﹤0.01% | 2879 |
|
|
2023
Q4 | – | Sell |
-3,139
| Closed | -$63.1K | – | 2995 |
|
|
2023
Q3 | $63.1K | Hold |
3,139
| – | – | ﹤0.01% | 2918 |
|
|
2023
Q2 | $84.3K | Buy |
3,139
+1,222
| +64% | +$32.8K | ﹤0.01% | 2903 |
|
|
2023
Q1 | $112K | Hold |
1,917
| – | – | ﹤0.01% | 2714 |
|
|
2022
Q4 | $97.8K | Sell |
1,917
-18
| -0.9% | -$918 | ﹤0.01% | 2803 |
|
|
2022
Q3 | $158K | Sell |
1,935
-53
| -3% | -$4.34K | ﹤0.01% | 2683 |
|
|
2022
Q2 | $135K | Buy |
1,988
+21
| +1% | +$1.42K | ﹤0.01% | 2820 |
|
|
2022
Q1 | $217K | Sell |
1,967
-586
| -23% | -$64.8K | ﹤0.01% | 2720 |
|
|
2021
Q4 | $246 | Sell |
2,553
-59
| -2% | -$6 | ﹤0.01% | 2761 |
|
|
2021
Q3 | $228K | Sell |
2,612
-66
| -2% | -$5.76K | ﹤0.01% | 2891 |
|
|
2021
Q2 | $415K | Sell |
2,678
-44
| -2% | -$6.82K | ﹤0.01% | 2568 |
|
|
2021
Q1 | $430K | Sell |
2,722
-2
| -0.1% | -$316 | ﹤0.01% | 2384 |
|
|
2020
Q4 | $632K | Buy |
2,724
+83
| +3% | +$19.3K | ﹤0.01% | 2065 |
|
|
2020
Q3 | $578K | Sell |
2,641
-49
| -2% | -$10.7K | ﹤0.01% | 1930 |
|
|
2020
Q2 | $726K | Buy |
2,690
+254
| +10% | +$68.6K | ﹤0.01% | 1773 |
|
|
2020
Q1 | $702K | Buy |
2,436
+171
| +8% | +$49.3K | ﹤0.01% | 1669 |
|
|
2019
Q4 | $651K | Sell |
2,265
-122
| -5% | -$35.1K | ﹤0.01% | 1902 |
|
|
2019
Q3 | $352K | Sell |
2,387
-10
| -0.4% | -$1.48K | ﹤0.01% | 2224 |
|
|
2019
Q2 | $215K | Buy |
2,397
+233
| +11% | +$20.9K | ﹤0.01% | 2597 |
|
|
2019
Q1 | $190K | Buy |
2,164
+144
| +7% | +$12.6K | ﹤0.01% | 2455 |
|
|
2018
Q4 | $284K | Sell |
2,020
-50
| -2% | -$7.03K | ﹤0.01% | 2184 |
|
|
2018
Q3 | $529K | Sell |
2,070
-274
| -12% | -$70K | ﹤0.01% | 2250 |
|
|
2018
Q2 | $598K | Buy |
2,344
+615
| +36% | +$157K | ﹤0.01% | 2245 |
|
|
2018
Q1 | $348K | Sell |
1,729
-53
| -3% | -$10.7K | ﹤0.01% | 2602 |
|
|
2017
Q4 | $256K | Buy |
1,782
+43
| +2% | +$6.18K | ﹤0.01% | 2827 |
|
|
2017
Q3 | $287K | Sell |
1,739
-55
| -3% | -$9.08K | ﹤0.01% | 2696 |
|
|
2017
Q2 | $243K | Buy |
1,794
+373
| +26% | +$50.5K | ﹤0.01% | 2853 |
|
|
2017
Q1 | $274K | Buy |
1,421
+190
| +15% | +$36.6K | ﹤0.01% | 2611 |
|
|
2016
Q4 | $173K | Buy |
1,231
+117
| +11% | +$16.4K | ﹤0.01% | 2898 |
|
|
2016
Q3 | $162K | Sell |
1,114
-23
| -2% | -$3.35K | ﹤0.01% | 2930 |
|
|
2016
Q2 | $115K | Buy |
1,137
+115
| +11% | +$11.6K | ﹤0.01% | 3158 |
|
|
2016
Q1 | $133K | Buy |
1,022
+25
| +3% | +$3.25K | ﹤0.01% | 2888 |
|
|
2015
Q4 | $198 | Buy |
997
+27
| +3% | +$5 | ﹤0.01% | 2674 |
|
|
2015
Q3 | $153 | Buy |
970
+21
| +2% | +$3 | ﹤0.01% | 2868 |
|
|
2015
Q2 | $387 | Buy |
949
+310
| +49% | +$126 | ﹤0.01% | 2300 |
|
|
2015
Q1 | $293 | Buy |
639
+88
| +16% | +$40 | ﹤0.01% | 2449 |
|
|
2014
Q4 | $309 | Sell |
551
-14
| -2% | -$8 | ﹤0.01% | 2325 |
|
|
2014
Q3 | $296 | Buy |
565
+56
| +11% | +$29 | ﹤0.01% | 2350 |
|
|
2014
Q2 | $355K | Buy |
509
+135
| +36% | +$94.2K | ﹤0.01% | 2297 |
|
|
2014
Q1 | $174 | Buy |
+374
| New | +$174 | ﹤0.01% | 2816 |
|